AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.
Martínez-Cardona C, Lozano-Ruiz B, Bachiller V, Peiró G, Algaba-Chueca F, Gómez-Hurtado I, Such J, Zapater P, Francés R, González-Navajas JM.
Martínez-Cardona C, et al. Among authors: zapater p.
Int J Cancer. 2018 Dec 1;143(11):2997-3007. doi: 10.1002/ijc.31827. Epub 2018 Oct 9.
Int J Cancer. 2018.
PMID: 30133699